Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-110147
Filing Date
2024-09-27
Accepted
2024-09-27 21:00:28
Documents
1
Period of Report
2024-06-07

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 3491
  Complete submission text file 0000950170-24-110147.txt   5487
Mailing Address 828 WINTER STREET WALTHAM MA 02451
Business Address 828 WINTER STREET WALTHAM MA 02451 617-833-1027
Xilio Therapeutics, Inc. (Issuer) CIK: 0001840233 (see all company filings)

EIN.: 851623397 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 501 SILVERSIDE ROAD SUITE 87AVA WILMINGTON DE 19809
Business Address 501 SILVERSIDE ROAD SUITE 87AVA WILMINGTON DE 19809 (302) 992-8882
GKCC, LLC (Reporting) CIK: 0001977769 (see all company filings)

State of Incorp.: DE
Type: 3 | Act: 34 | File No.: 001-40925 | Film No.: 241336357

Mailing Address C/O ELICIO THERAPEUTICS, INC. 451 D STREET, 5TH FLOOR, SUITE 501 BOSTON MA 02210
Business Address
Chudnovsky Yekaterina (Reporting) CIK: 0001979324 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40925 | Film No.: 241336358